Signpost Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	$845K	Sell	16,485 -16,580	-50%	-$850K	2.47%	7
2016 Q4	$1.24M	Sell	33,065 -1,300	-4%	-$48.7K	1.52%	7
2016 Q3	$2.33M	Hold	34,365	–	–	1.96%	8
2016 Q2	$1.91M	Hold	34,365	–	–	1%	8
2016 Q1	$2.16M	Buy	+34,365	New	+$2.16M	1.01%	13